M. Milanese (Pietra ligure (SV), Italy), M. Furian (Zürich, Switzerland), G. Kaltsakas (Athens, Greece), L. Lahousse (Ghent, Belgium)
Late Breaking Abstract - Small airway and parenchymal changes are frequent in V/P SPECT of smokers without COPD
M. Bajc (Lund, Sweden), L. Jarenbäck (Lund, Sweden), K. Wiklund (Lund, Sweden), J. Ankerst (Lund, Sweden), A. Lindqvist (Helsinki, Finland), L. Bjermer (Lund, Sweden)
|   |
Late Breaking Abstract - Dietary nitrate supplementation enhances the benefit of pulmonary rehabilitation in people with COPD
M. Pavitt (London, United Kingdom), R. Tanner (London, United Kingdom), A. Lewis (London, United Kingdom), S. Buttery (London, United Kingdom), B. Mehta (London, United Kingdom), H. Jefford (London, United Kingdom), K. Curtis (London, United Kingdom), W. Banya (London, United Kingdom), S. Husain (Maidstone, United Kingdom), K. Satkunam (London, United Kingdom), D. Shrikrishna (Taunton, United Kingdom), W. Man (London, United Kingdom), M. Polkey (London, United Kingdom), N. Hopkinson (London, United Kingdom)
| |
Late Breaking Abstract - Combined Use of Inspiratory and Expiratory Threshold Pressure Training with Data Monitor in COPD
X. Chen (Guangzhou, China), W. Xu (Guangzhou, China)
| |
Late Breaking Abstract - Effects of a new Airway Clearance Technology versus manual physiotherapy in COPD
F. Mihaltan (Bucharest, Romania), L. Morin (Aix-en-Provence, France), C. Borcea (Bucharest, Romania), A. Costantin (Bucharest, Romania), A. Pahontu (Bucharest, Romania), L. Marinescu (Bucharest, Romania), V. Cosei (Bucharest, Romania)
| |
Late Breaking Abstract - Cardio-pulmonary exercise test indicators of stress left ventricle diastolic dysfunction in non-severe COPD patients
R. Cherneva (Sofia, Bulgaria), Z. Cherneva (Sofia, Bulgaria), D. Valev (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria)
| |
Late Breaking Abstract - Dietary nitrate supplementation increases exercise endurance time in COPD patients using ambulatory oxygen
M. Pavitt (London, United Kingdom), A. Lewis (London, United Kingdom), S. Buttery (London, United Kingdom), B. Fernandez (Southampton, United Kingdom), M. Mikus-Lelinska (Southampton, United Kingdom), M. Feelisch (Southampton, United Kingdom), M. Polkey (London, United Kingdom), N. Hopkinson (London, United Kingdom)
| |
Using the volumetric capnography method in assessing the functional respiratory status of a patient with COPD
I. Ponomareva (Rryazan, Russian Federation), S. Subbotin (Rryazan, Russian Federation), V. Abrosimov (Rryazan, Russian Federation)
| |
Assessment of the physical capacity in patients hospitalized with COPD
M. Petrans (Riga, Latvia), M. Tirzite (Riga, Latvia)
| |
Is the “Sit-to-stand test” a good tool for evaluating oxygen desaturation in COPD?
A. Fernandes (Matosinhos, Portugal), Z. Camilo (Matosinhos, Portugal), G. Luís (Matosinhos, Portugal), I. Neves (Matosinhos, Portugal), J. Ferreira (Matosinhos, Portugal), P. Simão (Matosinhos, Portugal)
| |
Maximal voluntary inspiratory breath holding time test in patients with chronic obstructive pulmonary disease
A. Slim (tunis, Tunisia), A. Hedhli (tunis, Tunisia), S. Cheikh Rouhou (tunis, Tunisia), N. Mbarek (tunis, Tunisia), A. Taboubi (tunis, Tunisia), S. Benkhaled (tunis, Tunisia), Y. Ouahchi (tunis, Tunisia), J. Cherif (tunis, Tunisia), M. Mjid (tunis, Tunisia), S. Toujani (tunis, Tunisia), S. Merai (tunis, Tunisia)
| |
Multi-night continuous nocturnal oxygen saturation measurements in patients with COPD
J. Buekers (Mol, Belgium), J. Aerts (Leuven, Belgium), J. Theunis (Mol, Belgium), A. Vaes (Horn, Netherlands), E. Wouters (Horn, Netherlands), M. Spruit (Horn, Netherlands), P. De Boever (Mol, Belgium)
| |
Does the decrease in KCO go typically with DLCO decrease in obstructive pulmonary diseases? The relationship with DLCO, KCO, VA and VA/TLC in patients with COPD>
E. Sönmez (Kocaeli, Turkey), G. Erdogan (Kocaeli, Turkey), H. Alahdab (Kocaeli, Turkey), M. Uysal (Istanbul, Turkey)
| |
Cough reflex sensitivity in exacerbations of chronic obstructive pulmonary disease
P. Cho (London, United Kingdom), H. Fletcher (London, United Kingdom), I. Patel (London, United Kingdom), C. Jolley (London, United Kingdom), R. Turner (London, United Kingdom), S. Birring (London, United Kingdom)
| |
Peripheral muscle strength and COPD assessment test
G. Bianzeno (Botucatu, Brazil), J. Zucchi (Botucatu, Brazil), L. Machado (Botucatu, Brazil), A. Peralta (Botucatu, Brazil), L. Caram (Botucatu, Brazil), S. Tanni (Botucatu, Brazil), I. Godoy (Botucatu, Brazil), R. Ferrari (Botucatu, Brazil)
| |
COPD and Swallowing disorders: Clinical assessment by Fiberoptic Evaluation of Swallowing (FEES)
A. VILLABONA RUEDA (Baltimore, United States of America), G. Estévez Ramírez (Bucaramanga, Colombia), H. Paez Quientro (Bucaramanga, Colombia), T. Mendoza Herrera (Bucaramanga, Colombia), O. Castillo Mier (Floridablanca, Colombia), X. Alarcon Serrano (Bucaramanga, Colombia), J. Rojas Rodriguez (Bucaramanga, Colombia), J. Chacon Manosalva (Bucaramanga, Colombia), M. Chacon Manosalva (Bucaramanga, Colombia), J. Fajardo Rivero (Bucaramanga, Colombia)
| |
Signs of mental confusion and asterixis in hypercapnic COPD patients are attributable to elevated blood levels of ammonia
S. Michaelides (Athens, Greece), A. Michailidis (Athens, Greece), G. Bablekos (Athens, Greece), V. Skopas (Athens, Greece), N. Trakas (Athens, Greece), N. Koulouris (Athens, Greece)
| |
Relationship between the integrity of the cell membrane and hypoxia with hypercapnia in patients with hospitalized cardiorespiratory failure
C. Olivo-Villalobos (Mexico City, Mexico), D. González (Mexico City, Mexico), A. Orea-Tejeda (Mexico City, Mexico), R. Sánchez-Santillán (Mexico City, Mexico), G. Dávila-Said (Mexico City, Mexico), C. Chávez-Méndez (Mexico City, Mexico), V. Peláez-Hernández (Mexico City, Mexico), O. Pérez-Bautista (Mexico City, Mexico), M. Rivera-Rodriguez (Mexico City, Mexico), L. Castillo-Aguilar (Mexico City, Mexico), K. Balderas-Muñoz (Mexico City, Mexico), L. Hernández-Urquieta (Mexico City, Mexico)
| |
Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients
M. Mirdamadi (Tehran, Islamic Republic of Iran), H. Sadeghi (Tehran, Islamic Republic of Iran), A. Safaei (Tehran, Islamic Republic of Iran), M. Salesi (Tehran, Islamic Republic of Iran)
| |
Correlation of spirometric value to 2D ECHO parameters for diagnosis of pulmonary hypertension in COPD
A. Kumar (patna, India), D. Rai (patna, India)
| |
Impact of chronic obstructive pulmonary disease and heart failure on the phase angle in hospitalized subjects
G. Dávila Said (Mexico City, Mexico), D. González-Islas (Mexico City, Mexico), A. Orea-Tejeda (Mexico City, Mexico), C. Olivo-Villalobos (Mexico City, Mexico), C. Chávez-Méndez (Mexico City, Mexico), R. Sánches-Santillán (Mexico City, Mexico), L. Castillo-Aguilar (Mexico City, Mexico), V. Peláez-Hernández (Mexico City, Mexico), R. Pérez-Padilla (Mexico City, Mexico), R. Hernández-Zenteno (Mexico City, Mexico), M. Rivera-Rodríguez (Mexico City, Mexico), K. Balderas-Muñoz (Mexico City, Mexico), L. Hernández-Urquieta (Mexico City, Mexico)
| |